New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
18:15 EDTTSO, APOL, MPC, VLO, SAVE, HFC, NURO, PPHMOn The Fly: After Hours Movers
UP AFTER EARNINGS: Peregrine Pharmaceuticals (PPHM), up 2.3% after reports fourth quarter results. ALSO HIGHER: Spirit Airlines (SAVE), up 1.5% after Lone Pine Capital reported a 6% passive stake. LOWER: Apollo Education (APOL), down 6.2% following an announcement that the Department of Education intends to conduct an ordinary course program review of University of Phoenix... Neurometrix (NURO), down just under 1% after the company files to sell 5.89M shares of common stock for holders. NOTABLE: Valero Energy (VLO), down 3.4% after announcing second quarter guidance below analyst estimates... Tesoro (TSO), down almost 1%, HollyFrontier (HFC), down marginally, and Marathon Petroleum (MPC), down fractionally, are also lower following Valero Energy's announcement.
News For PPHM;SAVE;APOL;NURO;VLO;TSO;HFC;MPC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
June 30, 2015
09:26 EDTAPOLOn The Fly: Pre-market Movers
Subscribe for More Information
08:39 EDTAPOLApollo Education downgraded on enrollment uncertainty at BofA/Merrill
Subscribe for More Information
08:17 EDTAPOLApollo Education price target lowered to $20 from $29 at BMO Capital
BMO Capital cut its price target on Apollo after the company reported higher than expected Q3 EPS but lowered its fiscal 2015 guidance. The firm says that the company's Q3 enrollment and revenue were "subpar," and it thinks the company will continue to shrink. However, BMO adds that it still believes that "the stock is worth looking at on a sum of the parts basis." It keeps an Outperform rating on the shares.
June 29, 2015
19:01 EDTAPOLOn The Fly: After Hours Movers
HIGHER: Juno Therapeutics (JUNO), up 38.4% after announcing immunotherapy collaboration with Celgene (CELG)... Kite Pharma (KITE) and Lion Biotechnologies (LBIO) are up 8.7% and 5.7% respectively, following Juno's collaboration with Celgene. DOWN AFTER EARNINGS: CHC Group (HELI), down 8%... Apollo Education (APOL), down 6.2%. ALSO LOWER: EnteroMedics (ETRM), down 12.4% after filing to sell common stock and warrants... Celgene (CELG), down 1% after Juno announces immunotherapy collaboration.
17:52 EDTAPOLApollo Education sees FY16 student enrollment about 150,000 students
Subscribe for More Information
16:12 EDTAPOLApollo Education revises FY15 revenue view to $2.6B-$2.62B, consensus $2.63B
Subscribe for More Information
16:10 EDTAPOLApollo Education reports Q3 EPS 53c ex-items, consensus 47c
Subscribe for More Information
15:23 EDTAPOLNotable companies reporting after market close
Subscribe for More Information
13:27 EDTAPOLApollo Education technical notes ahead of earnings
The stock is trading close to its 52-week lows ahead of results, in a strongly bearish downtrend. If the news continues to be as bearish or more bearish than current expectations, there could be more downside to come. Support levels to watch below the current price of $15.73 would be at $14.42, $13.50, and $12.50. If the news is a bullish surprise, upside would be at $16.78, $17.54, and $18.36.
07:59 EDTAPOLApollo Education post-earnings rally could be brief, WSJ says
Subscribe for More Information
07:34 EDTAPOLApollo Education July volatility elevated into Q3 and outlook
Subscribe for More Information
June 26, 2015
17:51 EDTTSOFinal decision on Tesoro $210M railport project delayed until 2016, Reuters says
Subscribe for More Information
June 25, 2015
08:40 EDTPPHMPeregrine granted keu EU patent for bavituximab
Peregrine Pharmaceuticals announced that the European Patent Office, or EPO, has granted Patent Number 2,269,656, titled "Selected Antibodies Binding to Aminophospholipids and their Use in Treatment, Such as Cancer”. This important patent covers bavituximab as a composition of matter and for use in treating cancer including in combination with radiotherapy or chemotherapy, such as with docetaxel. The new patent covers bavituximab as a composition of matter, a range of related antibodies, including humanized and chain-shuffled antibodies and other sequence variations and their broad use in any diagnosis or therapy. The new patent also covers antibody drug conjugates, diagnostic and imaging constructs, liposomal and pharmaceutical combinations of bavituximab and related antibodies.
June 24, 2015
14:57 EDTAPOLApollo Education July volatility elevated into Q3 and outlook
Apollo Education July call option implied volatility is at 68. August is at 49; compared to its 52-week range of 27 to 67, suggesting large July price movement into the expected release of Q3 results on June 29.
June 23, 2015
07:12 EDTSAVESpirit Airlines initiated with an Overweight at Morgan Stanley
Subscribe for More Information
June 18, 2015
10:21 EDTSAVESouthwest, Spirit retreat after analysts downgrade shares
Southwest Airlines (LUV) and Spirit Airlines (SAVE) are falling after both airline stocks received downgrades from research firms this morning. Barclays downgraded Southwest, while Credit Suisse cut its rating on Spirit. WHAT'S NEW: Barclays analyst David Fintzen lowered his rating on Southwest to Underweight from Overweight, saying that the stock's valuation is above peer levels even though its outlook is no better than its large competitors. Moreover, the company's margins could drop in 2016 because of its "outsized growth," the analyst warned. Credit Suisse analyst Julie Yates downgraded Spirit Airlines to Neutral from Outperform, as she believes the airlines is facing more aggressive competitor fares. American Airlines (AAL) is offering lower fares than Spirit on five of the latter company's ten top ten routes for travel two months from reservation dates, the analyst stated. Moreover, Spirit's second quarter margins may come in below its guidance and the airline will probably reduce its margin outlook when its reports its Q2 results in late July, Yates predicted. WHAT'S NOTABLE: Barclays' Fintzen was more upbeat on Spirit, continuing to identify it as his top pick among airlines. More broadly, Fintzen remains generally upbeat on airline stocks, predicting that the industry's profitability will be "far more durable" than the market believes. The sector's competition is balanced, and it has increased its capacity and airplane purchases much less than in prior periods of oil price declines, according to Fintzen. Additionally, the airline stocks' multiples remain overly depressed, he believes. He says that the following stock in the sector can climb about 50%: Spirit, American, Delta (DAL), and United (UAL). PRICE ACTION: In early trading, Southwest dropped 2.2% to $33.11 and Spirit slid 2.4% to $60.91.
10:01 EDTSAVEOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Arch Capital (ACGL) downgraded to Market Perform from Outperform at BMO Capital... Bankrate (RATE) downgraded on revenue headwinds at SunTrust... Carter's (CRI) downgraded to Neutral from Buy at Sterne Agee CRT... Lumenis (LMNS) downgraded to Market Perform from Outperform at Wells Fargo... Nimble Storage (NMBL) downgraded to Hold from Buy at Wunderlich... Southwest (LUV) downgraded to Underweight from Overweight at Barclays... Spirit Airlines (SAVE) downgraded to Neutral from Outperform at Credit... Webster Financial (WBS) downgraded to Underweight from Equal Weight at Morgan Stanley.
06:58 EDTSAVESpirit Airlines downgraded to Neutral from Outperform at Credit Suisse
Subscribe for More Information
05:41 EDTSAVESouthwest downgraded to Underweight from Overweight at Barclays
Barclays analyst David Fintzen downgraded Southwest (LUV) two notches to Underweight from Overweight saying the company has moved from a margin expansion story to an "average" big four airline trading at a premium valuation. Fintzen expects Southwest's growth to normalize in 2016 and cut his price target for shares to $39 from $50. The stock closed yesterday down 7c to $33.84. The analyst coupled the downgrade with an upgrade of Align Technology (ALGN) to Equal Weight. He remains bullish on airlines, with Spirit Airlines (SAVE) remaining his top pick, followed by Delta Air Lines (DAL), American Airlines (AAL) and United Continental (UAL). Fintzen sees 50% average upside in those four names.
June 16, 2015
06:29 EDTAPOLApollo Group volatility increases into Q3 and enrollment outlook
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use